Episode 152: “State of the Union” in a Changing Biotech and Science Policy Landscape

How can scientists and biotech leaders move forward when the policy and funding landscape keeps shifting beneath their feet?In this episode, host Elaine Hamm, PhD, welcomes back Srinu Sonti, JD, Principal at Lewis-Burke Associates, for an update on the current state of science and healthcare policy. Srinu explores what changes in federal research funding, healthcare policy, and international collaboration could mean for scientists, universities, and early-stage biotech companies – and where opportunities may still be emerging.In this episode, you’ll discover:How changes in science funding, healthcare policy, and federal priorities could affect researchers and biotech companies in the months ahead.Why AI, organ-on-a-chip technologies, in silico models, and other new approach methodologies could create new opportunities for research and drug development.How scientists and biotech leaders can advocate for their work by engaging policymakers, communicating their impact, and demonstrating the economic and public health value of scientific innovation.Tune in for a practical look at how scientists and biotech leaders can navigate uncertainty, identify emerging opportunities, and make sure their voices are heard as the science policy landscape continues to evolve.Links: Connect with Srinu Sonti, JD, and learn about Lewis-Burke Associates.Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.Check out Help a Reporter Out.Check out our previous episode with Srinu.Connect with Ian McLachlan, BIO from the BAYOU producer.Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.